Page 2 - Phenomix Sciences News Today

Ever since injections promising to help people lose weight hit the shelves, interest around the world has been phenomenal. So high was demand, companies were finding it difficult to keep up with the demand.

Phenomix Sciences announced it has been awarded the first patent related to its obesity phenotyping technology for precision medicine.

/PRNewswire/ -- Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data-driven precision medicine to obesity treatment,...

It sounds like a simple solution to a complicated problem: Find out what kind of obesity you have based on a one-time genetic saliva test to get a better idea of what treatments might work.

You've likely seen the commercials during the nightly news — you know, the ones proclaiming "O-O-O-Ozempic!" to the catchy 1974 tune "Magic" by the band Pilot.

/PRNewswire/ -- With forecasts predicting that obesity drug sales will quadruple in the next five years to $11B annually, it is crucial for providers to know...

Phenomix Sciences Launches First-of-its-Kind Test to Predict Obesity Phenotype Resulting in Precision Medicine Treatment Options

The American Medical Association (AMA) is at the forefront of the transformation in healthcare delivery, and patient experience brought about by digital health technologies and artificial intelligence (AI).

TikTok users cannot get enough of Ozempic and its sister drug, Wegovy, but does it come at a cost?

Phenomix Sciences Launches Obesity Biobanking Registry Studying Personalized Treatment Options Based on Genetics